As Featured in PLOS Global Public Health
Neonatal jaundice is a prevalent and serious condition that affects newborns around the world, particularly in low and middle-income countries (LMICs). The quest for an effective, affordable, and accurate diagnostic tool has been long. The introduction of BiliDx, as detailed in the recent PLOS Global Public Health article “Design and field evaluation of a lateral flow cassette device for point-of-care bilirubin measurement,” represents a crucial step forward in this journey.
At DCN Dx, we are honored that our experts contributed to the design of the BiliDx lateral flow strip, a product now produced at scale using traditional manufacturing techniques. This unique design has allowed a remarkable advancement in the healthcare sector.
BiliDx holds multi-dimensional importance. In regions plagued with high mortality rates due to neonatal jaundice, timely detection and treatment are paramount. Current technologies often fail to deliver either due to high costs or subpar accuracy. BiliDx stands as a solution, offering hope where it is needed most.
The product was scrupulously evaluated at hospitals in Nigeria and Malawi, and the results are promising. With 96.9% of samples measured aligning with the clinical decision of the reference standard, BiliDx demonstrates an impressive performance level.
This development opens doors to low-cost, point-of-care bilirubin measurement tools that can efficiently identify jaundiced neonates and initiate phototherapy treatment. In areas like sub-Saharan Africa, where neonatal jaundice mortality is stark, BiliDx offers a lifeline.
DCN Dx’s collaboration in this important project is a testament to our dedication to innovative healthcare solutions that resonate on a global scale. Our team’s expertise has led to not just a product but a movement towards better neonatal care worldwide.
To explore more about BiliDx and the profound impact it is poised to make, read the full article, “Design and field evaluation of a lateral flow cassette device for point-of-care bilirubin measurement.”
